2018 annual financial data

Fulcrum Therapeutics 2018 Net margin

Fulcrum Therapeutics 2018 net margin with verified reported values.

Direct answer

Net margin was Not calculable.

Operating income was -33,498,000 USD and net income was -32,588,000 USD.
Operating cash flow was -22,562,000 USD.

Get free Fulcrum Therapeutics email updates.

Bullstory sends one daily email when new analysis or important company news is available.

Verified data

Revenue
0 USD
Operating income
-33,498,000 USD
Net income
-32,588,000 USD
Operating cash flow
-22,562,000 USD